Showing results (1791-1800 of 1,843) with videos related to
Sort By:
Pageof 185
Oncogene|May 3, 2019
Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesisNadine Rohwer, Sandra Jumpertz, Merve Erdem, et al.Genes & Development|December 17, 2014
HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasiaTaranjit Singh Rai, John J Cole, David M Nelson, et al.Nature Genetics|November 12, 2005
Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathyJan Senderek, Michael Krieger, Claudia Stendel, et al.Bioorganic & Medicinal Chemistry Letters|January 2, 2008
BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic characterBrian Clarke, Emmanuel Demont, Colin Dingwall, et al.Journal of the American Chemical Society|October 14, 2004
Local and nanoscale structure and speciation in the PuO2+x-y(OH)2y.zH2O systemSteven D Conradson, Bruce D Begg, David L Clark, et al.Cancer|December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2021
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research GroupRoisin M Connolly, Fengmin Zhao, Kathy D Miller, et al.Frontiers in Pharmacology|September 1, 2023
Defining and supporting a professional role for pharmacists associated with traditional and complementary medicines: a cross-country survey of pharmacistsJoanna E Harnett, Shane P Desselle, Marcília Baticy Fernandes, et al.JAMA Oncology|July 1, 2021
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical TrialOsama E Rahma, Greg Yothers, Theodore S Hong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1)Michèle Beau-Faller, Armelle Degeorges, Estelle Rolland, et al.Pageof 185